Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
In Good Company with Nicolai Tangen
00:00
Innovations in Cancer and Neurological Treatments
This chapter explores significant advancements in cancer treatment over the last five decades, focusing on personalized therapies and the impact of genomic understanding. It also highlights a healthcare company's leadership in pharmaceuticals and diagnostics, alongside their innovative approaches to tackle obesity and neurological diseases. The discussion introduces a groundbreaking technology designed to enhance drug delivery across the blood-brain barrier, aiming to improve treatments for conditions like Alzheimer's and Parkinson's.
Transcript
Play full episode
